Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CLIR
CLIR logo

CLIR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy ClearSign Technologies Corp (CLIR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
5.450
1 Day change
2.25%
52 Week Range
11.200
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

ClearSign Technologies Corp (CLIR) is not a strong buy for a beginner investor with a long-term focus at this time. Despite some positive revenue growth, the company's financial performance is inconsistent, with a net loss and declining EPS. Technical indicators are neutral, and there are no strong trading signals or catalysts to suggest immediate upside potential.

Technical Analysis

The MACD is above 0 but positively contracting, indicating a lack of strong momentum. RSI is neutral at 48.004, and moving averages are converging, suggesting no clear trend. The stock is trading below its pivot point of 5.883, with key support at 4.642 and resistance at 7.125.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
4

Positive Catalysts

  • The company reported a 44% revenue growth in 2025, driven by a significant order in the petrochemical sector. Gross margin increased YoY in Q4 2025.

Neutral/Negative Catalysts

  • Increased warranty accruals and non-recurring legal fees impacted profitability. Net cash used in operations increased YoY.

Financial Performance

In Q4 2025, revenue increased by 522.20% YoY to $3.67 million. However, net income dropped by 73.28% YoY to -$311,000, and EPS declined by 71.43% YoY to -0.06. Gross margin improved YoY to 21.93%, but overall financial performance remains weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

H.C. Wainwright adjusted the price target to $20 from $2 due to a 1-for-10 reverse split and maintained a Buy rating. However, this adjustment is not based on fundamental improvements in the business.

Wall Street analysts forecast CLIR stock price to fall
1 Analyst Rating
Wall Street analysts forecast CLIR stock price to fall
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 5.450
sliders
Low
2
Averages
2
High
2
Current: 5.450
sliders
Low
2
Averages
2
High
2
H.C. Wainwright
H.C. Wainwright
Buy
maintain
$2 -> $20
AI Analysis
2026-04-14
Reason
H.C. Wainwright
H.C. Wainwright
Price Target
$2 -> $20
AI Analysis
2026-04-14
maintain
Buy
Reason
H.C. Wainwright adjusted the firm's price target on ClearSign to $20 from $2 and keeps a Buy rating on the shares. The firm cites the company's 1-for-10 reverse split for the target change.

People Also Watch